Development of Quantitative PET Imaging Probes for Neuroinflammation

炎症是生物体的免疫反应的保护性尝试，以去除有害刺激并启动组织的愈合过程。炎症过程通常是有益的，但未经检查的炎症也可能导致许多疾病，如花粉热，动脉粥样硬化和类风湿性关节炎。正是由于这个原因，炎症通常受到身体的密切调节。免疫特权？这些组织是由一系列被称为血脑屏障的内皮细胞与身体的其他部分隔开的，血脑屏障可以防止大多数感染到达脆弱的神经组织。因此，CNS中的炎症（神经炎症）是由一种独特的细胞类型小胶质细胞介导的。小胶质细胞是脑中称为胶质细胞的细胞群的非神经元部分的一部分，另一种胶质细胞是星形胶质细胞和少突胶质细胞。静止的小胶质细胞具有分支形态，因为它们不断移动并分析CNS中受损的神经元、斑块和感染因子;每当检测到异常时，小胶质细胞进入活跃状态并经历几种形态学变化，包括分支的增厚和收缩、免疫分子的表达、细胞毒性因子、募集分子和促炎信号分子的分泌。因此，小胶质细胞活化在任何脑病理状态的早期就存在，并且小胶质细胞活化的体内检测是关键的诊断目的。此外，小胶质细胞慢性激活也被认为是神经退行性疾病（如阿尔茨海默病）发生和/或进展的关键因素。帕金森病与帕金森？的疾病。该项目旨在使用正电子发射断层扫描（PET）技术为小胶质细胞提供最佳的成像生物标志物。PET是一种核医学模式，能够对放射性标记化合物的分布进行成像。对用PET放射性示踪剂成像小胶质细胞的兴趣是这样的，现在全世界提出了50多种靶向小胶质细胞的放射性示踪剂。在这项培训计划的背景下，我们将测试最有前途的PET小胶质细胞示踪剂，设计适当的数据处理程序和指标，以便选择未来用于诊断，研究和药物开发的最佳标记物。

Inflammation is a protective attempt by the immune response of the organism to remove the injurious stimuli as well as to initiate the healing process for the tissue. The inflammatory process is generally beneficial but an inflammation that runs unchecked can also lead to a host of diseases, such as hay fever, atherosclerosis, and rheumatoid arthritis. It is for this reason that inflammation is normally closely regulated by the body.The brain and spinal cord are considered ?immune privileged? tissues in that they are separated from the rest of the body by a series of endothelial cells known as the blood-brain barrier, which prevent most infections from reaching the vulnerable nervous tissue. For this reason, inflammation in the CNS (Neuroinflammation) is mediated by a unique cell type, microglia. Microglia are part of the non-neuronal part of the cell population in the brain called glia, the other glial cell being the astrocytes and the oligodendrocytes. Quiescent microglia have a ramified morphology as they are constantly moving and analyzing the CNS for damaged neurons, plaques, and infectious agents; whenever an anomaly is detected, microglia enter an active state and undergo several morphological changes including the thickening and retraction of branches, the expression of immunomolecules, the secretion of cytotoxic factors, recruitment molecules and pro-inflammatory signaling molecules. Microglial activation is therefore present early in any pathological state of the brain and the in-vivo detection of microglial activation is a key diagnostic aim. Besides, microglia chronic activation has also been suggested as a key factor in the inception and/or progression of neurodegenerative diseases like Alzheimer?s disease and Parkinson?s disease. This project aims at delivering an optimal imaging biomarker for microglia using Positron Emission Tomography (PET) technology. PET is a Nuclear Medicine modality that is able to image the distribution of radioactive labelled compounds. The interest in imaging microglia with PET radiotracers is such that more than 50 radiotracers targeting microglia are now proposed world-wide. In the context of this training proposal, we will test the most promising PET microglia tracers, devise appropriate data-processing procedures and metrics that will allow the selection of the optimal marker to be used in the future in diagnostics, research and drug development.